Tops & Flops Stocks
| Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immune Design Corp | - | - | - | - | - | - | - |
| Heska Corp | 0.910% | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 0.440% | 24.301% | 31.445% | 138.955% | 103.949% | -71.576% | - |
| Hepion Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Healthstream Inc. | -0.790% | 0.000% | 8.696% | 12.613% | 4.167% | 15.741% | 9.075% |
| Harvard Bioscience | - | -5.161% | -13.529% | -45.556% | -38.494% | -50.169% | 37.769% |
| Halyard Health | -0.530% | 0.541% | 6.286% | -11.429% | -7.921% | -43.976% | -50.446% |
| Gritstone Oncology Inc | -1.880% | 11.119% | 9.214% | -57.716% | -58.854% | -89.738% | - |
| Glycomimetics Inc. | -1.960% | 3.353% | -84.534% | -86.311% | -88.407% | -87.404% | - |
| Geron Corp. | 0.060% | -4.877% | -2.430% | 16.964% | 73.425% | 191.709% | 142.918% |
| Genocea Biosciences Inc. | - | - | - | - | - | - | - |
| Genmark Diagnostics | - | - | - | - | - | - | - |
| Genfit S.A. | -0.480% | 8.501% | 15.846% | -2.964% | 4.438% | 14.368% | -82.521% |
| Genesis Healthcare Inc. | - | - | - | - | - | - | - |
| G1 Therapeutics | 2.070% | -7.545% | 3.278% | 49.811% | 44.364% | -77.184% | - |
| F-Star Therapeutics Inc. | 18.750% | - | - | - | - | - | - |
| Fortress Biotech Inc. | -12.900% | - | - | - | - | - | - |
| Forte Biosciences Inc. | -4.670% | -12.069% | -24.444% | -43.646% | -20.930% | -98.241% | - |
| Fonar Corp. New | - | -12.583% | -15.385% | -15.385% | -25.424% | -12.583% | -29.675% |
| Fluidigm Corp. | - | -0.870% | -0.870% | 3.636% | 10.680% | -50.809% | - |
| Flexion Therapeutics Inc. | - | - | - | - | - | - | - |
| Five Prime Therapeutics | - | - | - | - | - | - | - |
| Fate Therapeutics Inc. | -2.620% | -12.568% | -24.421% | -29.884% | -4.528% | -94.394% | - |
| EyePoint Pharmaceuticals Inc. | -2.170% | -3.972% | -33.860% | 94.286% | -49.159% | 45.067% | - |
| Evolus Inc | 0.840% | 0.840% | 15.385% | 27.660% | 32.597% | 61.074% | - |